stands for Digital Object Identifier
and is the unique identifier for objects on the internet. It can be used to create persistent link and to cite articles.
Using DOI as a persistent link
To create a persistent link, add「http://dx.doi.org/」
before a DOI.
For instance, if the DOI of an article is 10.5297/ser.1201.002 , you can link persistently to the article by entering the following link in your browser: http://dx.doi.org/ 10.5297/ser.1201.002 。
The DOI link will always direct you to the most updated article page no matter how the publisher changes the document's position, avoiding errors when engaging in important research.
Cite a document with DOI
When citing references, you should also cite the DOI if the article has one. If your citation guideline does not include DOIs, you may cite the DOI link.
DOIs allow accurate citations, improve academic contents connections, and allow users to gain better experience across different platforms. Currently, there are more than 70 million DOIs registered for academic contents. If you want to understand more about DOI, please visit airiti DOI Registration （ doi.airiti.com ） 。
- Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M. and Nejati-Koshki, K. (2013) Liposome: classification, preparation, and applications. Nanoscale Res. Lett. 8: 102.
- Arai, M., Scandella, D. and Hoyer, L. W. (1989) Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid. J. Clin. Invest. 83: 1978-84.
- Aronstam, A., Kirk, P. J., McHardy, J., Culver-James, J. W., McLellan, D. S., Turk, P., Rainsford, S. G. and Slattery, M. (1977) Twice weekly prophylactic therapy in haemophilia A. J. Clin. Pathol. 30: 65-7.
- Bacon, C. L., Singleton, E., Brady, B., White, B., Nolan, B., Gilmore, R. M., Ryan, C., Keohane, C., Jenkins, P. V. and O'Donnell, J. S. (2011) Low risk of inhibitor formation in haemophilia A patients following en masse switch in treatment to a third generation full length plasma and albumin-free recombinant factor VIII product (ADVATE(R)). Haemophilia. 17: 407-11.
- Bloem, E., Meems, H., van den Biggelaar, M., Mertens, K. and Meijer, A. B. (2013) A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX. J. Biol. Chem. 288: 26105-11.
The cart has had several articles, so do you want to clear it, or add together to the cart?